Mechanism of splicing regulation of spinal muscular atrophy genes

RN Singh, NN Singh - RNA Metabolism in Neurodegenerative Diseases, 2018 - Springer
Spinal muscular atrophy (SMA) is one of the major genetic disorders associated with infant
mortality. More than 90% cases of SMA result from deletions or mutations of Survival Motor …

RRM–RNA recognition: NMR or crystallography… and new findings

GM Daubner, A Cléry, FHT Allain - Current opinion in structural biology, 2013 - Elsevier
To characterize protein–RNA recognition at the molecular level, structural biology has
turned out to be an indispensable approach. Detailed and direct insights into the mechanism …

Structural basis of a small molecule targeting RNA for a specific splicing correction

S Campagne, S Boigner, S Rüdisser, A Moursy… - Nature chemical …, 2019 - nature.com
Splicing modifiers promoting SMN2 exon 7 inclusion have the potential to treat spinal
muscular atrophy, the leading genetic cause of infantile death. These small molecules are …

Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice

Y Hua, TA Vickers, HL Okunola, CF Bennett… - The American Journal of …, 2008 - cell.com
survival of motor neuron 2, centromeric (SMN2) is a gene that modifies the severity of spinal
muscular atrophy (SMA), a motor-neuron disease that is the leading genetic cause of infant …

A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy

T Kashima, JL Manley - Nature genetics, 2003 - nature.com
Spinal muscular atrophy (SMA) is a relatively common neurodegenerative disease caused
by homozygous loss of the survival motor neuron 1 (SMN1) gene. Humans possess a linked …

Splicing of a Critical Exon of Human Survival Motor Neuron Is Regulated by a Unique Silencer Element Located in the Last Intron

NK Singh, NN Singh, EJ Androphy… - Molecular and cellular …, 2006 - Taylor & Francis
Humans have two nearly identical copies of the Survival Motor Neuron (SMN) gene, SMN1
and SMN2. In spinal muscular atrophy (SMA), SMN2 is not able to compensate for the loss …

Recurrent chimeric fusion RNAs in non-cancer tissues and cells

M Babiceanu, F Qin, Z Xie, Y Jia, K Lopez… - Nucleic acids …, 2016 - academic.oup.com
Gene fusions and their products (RNA and protein) were once thought to be unique features
to cancer. However, chimeric RNAs can also be found in normal cells. Here, we performed …

Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2

L Cartegni, ML Hastings, JA Calarco… - The American Journal of …, 2006 - cell.com
Spinal muscular atrophy is a neurodegenerative disorder caused by the deletion or mutation
of the survival-of-motor-neuron gene, SMN1. An SMN1 paralog, SMN2, differs by a C→ T …

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy

L Brichta, Y Hofmann, E Hahnen… - Human molecular …, 2003 - academic.oup.com
Proximal spinal muscular atrophy (SMA) is a common neuromuscular disorder causing
infant death in half of all patients. Homozygous absence of the survival motor neuron gene …

Valproic acid increases SMN levels in spinal muscular atrophy patient cells

CJ Sumner, TN Huynh, JA Markowitz… - Annals of Neurology …, 2003 - Wiley Online Library
Spinal muscular atrophy (SMA) is an inherited motor neuron disease caused by mutation of
the telomeric copy of the survival motor neuron gene (SMN1). Although a centromeric copy …